InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (13 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
13
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Graham Richard A, SVP, Développement. Director active across 1 company, notably Theravance Biopharma, Inc.. Cumulatively, 29 filings have been published. Breakdown: 0 buy · 13 sells. Total volume traded: €424k. History available since 20 May 2021. The latest transaction was disclosed on 20 February 2024 (Retenue fiscale). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Graham Richard A
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations29 total
19,294 shares@ US$8.927.8% of flowOrdinary SharesSEC:0001415889-24-004960:0
12,630 shares@ US$10.375.9% of flowOrdinary SharesSEC:0001415889-23-015448:0
2,482 shares@ US$10.221.2% of flowOrdinary SharesSEC:0001415889-23-015228:0
15,000 shares0Ordinary SharesSEC:0001415889-23-014680:0
2,482 shares@ US$9.031.0% of flowOrdinary SharesSEC:0001415889-23-014412:0
2,482 shares@ US$9.891.2% of flowOrdinary SharesSEC:0001415889-23-013342:0
10,461 shares@ US$9.704.6% of flowOrdinary SharesSEC:0001415889-23-012514:0
2,322 shares@ US$9.991.0% of flowOrdinary SharesSEC:0001415889-23-012271:0
2,322 shares@ US$9.841.0% of flowOrdinary SharesSEC:0001415889-23-011244:0
2,322 shares@ US$10.691.1% of flowOrdinary SharesSEC:0001415889-23-009963:0
10,460 shares@ US$11.215.3% of flowOrdinary SharesSEC:0001415889-23-008670:0
2,322 shares@ US$11.261.2% of flowOrdinary SharesSEC:0001415889-23-008228:0
2,323 shares@ US$11.881.2% of flowOrdinary SharesSEC:0001415889-23-006620:0
2,323 shares@ US$10.321.1% of flowOrdinary SharesSEC:0001415889-23-005044:0
2,323 shares@ US$10.051.1% of flowOrdinary SharesSEC:0001415889-23-004552:0
75,000 shares0Ordinary SharesSEC:0001415889-23-004271:0
12,057 shares@ US$10.445.8% of flowOrdinary SharesSEC:0001415889-23-003065:0
2,084 shares@ US$10.731.0% of flowOrdinary SharesSEC:0001415889-22-012077:0
27,350 shares@ US$10.8514.0% of flowOrdinary SharesSEC:0001415889-22-011669:0
2,800 shares@ US$11.201.5% of flowOrdinary SharesSEC:0001415889-22-011523:0
18,991 shares@ US$9.348.6% of flowOrdinary SharesSEC:0001415889-22-008981:0
4,906 shares@ US$9.71052.3% of flowOrdinary SharesSEC:0001415889-22-008835:0
15,086 shares@ US$8.796.3% of flowOrdinary SharesSEC:0001415889-22-008512:0
3,947 shares@ US$8.740.0039% mcap6.1% of flowOrdinary SharesSEC:0001415889-22-005629:0
20,377 shares@ US$9.619.1% of flowOrdinary SharesSEC:0001415889-22-001697:0
25 of 29 declarations
About Graham Richard A
GRAHAM RICHARD A is SVP, Développement at Theravance Biopharma, Inc. He has 29 filings in total, and, across the sampled recent filings from 2021-05-24 to 2024-02-22, the amounts show 0 EUR of buys and 423912 EUR of sells, with the dominant transaction nature listed as Retenue fiscale.
